Closed call · historical reference

H2020-JTI-IMI2-2015-06-two-stage · Development of an outcomes-focused data platform to empower policy makers and clinicians to optimize care for patients with hematologic malignancies

Specific Challenge:Hematologic malignancies (HMs) account for about one-third of cancer cases in children and about one-third of cancer deaths. Due to the rarity of the conditions and the diverse healthcare practice across EU, current healthcare systems are challenged with • lack of definition and…